Fig. 2From: Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort studyOverall survival of (a) the overall study population, (b) the HPV/p16-positive population, (c) the smoking population, and (d) the advanced age population that received primary chemoradiation with cisplatin versus cetuximabBack to article page